VVOS Other Disclosure
Huntsman Ronald Kirk · SEC Form 4 · Filed Sep 18, 2026
Other
Calculated transaction value
$50K
Huntsman Ronald Kirk Chief Executive Officer
VVOS
Transaction date
Jun 30, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 80 days later
VVOS daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Preferred Stock
- Quantity / price
- 85,910 shares @ $0.58
- SEC ownership
- Indirect
- Transaction code
- J
- Form
- 4
- Filing identifier
- 0001493152-26-043383
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$100K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vivos Therapeutics, Inc. VVOS Current | Other | Jun 30, 2026 | $50K |
| Vivos Therapeutics, Inc. VVOS | Other | Jun 30, 2026 | $50K |